Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Immunic Inc.’s current trading price is -85.20% away from its 52-week high, while its distance from the 52-week low is 56.76%. The stock’s price range during this period has varied between $1.11 and $11.76. The company, active in the Healthcare sector, saw a trading volume of around 0.77 million for the day, considerably lower average daily volume of 1.25 million observed over the last three months.
Immunic Inc. (IMUX) current stock price is $1.74. During the last trading session, the stock soared, reaching $1.92 after opening at $1.92. The stock’s lowest point was $1.73 before it closed at $1.92.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Immunic Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $11.76 on 10/13/22, and the lowest price during that time was $1.11, recorded on 12/19/22.
How Financial Performance Impacts Market Capitalization
Immunic Inc. (IMUX) has experienced a quarterly decline of -11.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 73.53M and boasts a workforce of 66 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7742, with a change in price of +0.3600. Similarly, Immunic Inc. recorded 1,212,217 in trading volume during the last 100 days, posting a change of +26.09%.
How IMUX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for IMUX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
IMUX Stock Stochastic Average
As of today, the raw stochastic average of Immunic Inc. over the last 50 days is at 55.21%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 31.78%. Further, the company’s Stochastic %K and %D values for the last 20 days were 65.07% and 77.92%, respectively.
IMUX Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 24.29%. However, over the last six months, the performance has been weaker by 32.82%. The price of IMUX increased 11.54% over the last 30 days. And in the last five days, it has fallen by -3.87%.